{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:31:19Z","timestamp":1791192679979,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.phrs.2016.04.002","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T11:51:31Z","timestamp":1459857091000},"page":"381-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease"],"prefix":"10.1016","volume":"107","author":[{"given":"Tiphaine","family":"Belleville-Rolland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yassine","family":"Sassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Decouture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Dreano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-S\u00e9bastien","family":"Hulot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Gaussem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christilla","family":"Bachelot-Loza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.04.002_bib0005","doi-asserted-by":"crossref","first-page":"13787","DOI":"10.1021\/bi701385t","article-title":"Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S. reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP","volume":"46","author":"Sauna","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2016.04.002_bib0010","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.1074\/jbc.M109.047290","article-title":"Characterization of an asymmetric occluded state of P-glycoprotein with two bound nucleotides: implications for catalysis","volume":"285","author":"Siarheyeva","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.04.002_bib0015","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1124\/jpet.108.136523","article-title":"The human multidrug resistance protein 4 (MRP4, ABCC4): functional analysis of a highly polymorphic gene","volume":"325","author":"Abla","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.04.002_bib0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2003.12.001","article-title":"Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat","volume":"40","author":"Denk","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0025","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/sj.tpj.6500451","article-title":"Variability in human hepatic MRP4 expression: influence of cholestasis and genotype","volume":"8","author":"Gradhand","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.phrs.2016.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/12487","article-title":"MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs","volume":"5","author":"Schuetz","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2016.04.002_bib0035","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"19","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.002_bib0040","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2016.04.002_bib0045","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1172\/JCI35067","article-title":"Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation","volume":"118","author":"Sassi","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.04.002_bib0050","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI45023","article-title":"Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice","volume":"121","author":"Hara","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.04.002_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1440-1681.2009.05272.x","article-title":"Multidrug resistance protein 4 mediates cAMP efflux from rat preglomerular vascular smooth muscle cells","volume":"37","author":"Cheng","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2012.02.018","article-title":"MRP4 and CFTR in the regulation of cAMP and b\u00e9ta-adrenergic contraction in cardiac myocytes","volume":"681","author":"Sellers","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0065","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1096\/fj.11-194027","article-title":"Regulation of cAMP homeostasis by the efflux protein MRP4 in cardiac myocytes","volume":"26","author":"Sassi","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2016.04.002_bib0070","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.1172\/JCI74349","article-title":"Cardiac myocyte\u2fffsecreted cAMP exerts paracrine action via adenosine receptor activation","volume":"124","author":"Sassi","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.04.002_bib0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev.physiol.66.032102.111604","article-title":"The extracellular cyclic AMP-adenosine pathway in renal physiology","volume":"66","author":"Jackson","year":"2004","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0304-4165(76)90253-1","article-title":"Extracellular metabolism of cyclic AMP","volume":"451","author":"Gorin","year":"1976","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.phrs.2016.04.002_bib0085","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1016\/S0021-9258(19)68876-9","article-title":"Hormonally sensitive cyclic AMP phosphodiesterase in liver cells. An ecto-enzyme","volume":"256","author":"Smoake","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.04.002_bib0090","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1523\/JNEUROSCI.09-08-02654.1989","article-title":"Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture","volume":"9","author":"Rosenberg","year":"1989","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.04.002_bib0095","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1523\/JNEUROSCI.14-05-02953.1994","article-title":"Beta-adrenergic aeceptor-mediated regulation of extracellular adenosine in cerebral cortex in culture","volume":"4","author":"Rosenberg","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2016.04.002_bib0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0006-8993(95)00668-G","volume":"617","author":"Rosenberg","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.04.002_bib0105","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.bjp.0707648","article-title":"Skeletal muscle expresses the extracellular cyclic AMP\u2fffadenosine pathway","volume":"153","author":"Chiavegatti","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0110","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/01.HYP.35.1.267","article-title":"A2B receptors mediate antimitogenesis in vascular smooth muscle cells","volume":"35","author":"Dubey","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.04.002_bib0115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/01.HYP.36.3.337","article-title":"Cardiac fibroblasts express the cAMP-adenosine pathway","volume":"36","author":"Dubey","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.04.002_bib0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/01.HYP.31.1.296","article-title":"Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells","volume":"31","author":"Dubey","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2016.04.002_bib0125","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI114399","article-title":"Beta-adrenergic stimulation of adenine nucleotide catabolism and purine release in human adipocytes","volume":"85","author":"Kather","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.phrs.2016.04.002_bib0130","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood-2003-04-1133","article-title":"Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels","volume":"103","author":"Sim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.1987.tb11310.x","article-title":"Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets","volume":"92","author":"Radomski","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0140","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1182\/blood-2011-03-339705","article-title":"Genome wide RNA-seq analysis of human and mouse platelet transcriptomes","volume":"118","author":"Rowley","year":"2011","journal-title":"e-Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0145","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","article-title":"The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways","volume":"120","author":"Burkhart","year":"2012","journal-title":"e-Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0150","doi-asserted-by":"crossref","first-page":"8710","DOI":"10.1021\/bi00099a032","article-title":"Identifying the molecular switches that determine whether (Rp)-cAMPS functions as an antagonist or an agonist in the activation of cAMP-dependent protein kinase I","volume":"30","author":"Dostmann","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2016.04.002_bib0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1432-1033.1987.tb13357.x","article-title":"Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases","volume":"167","author":"Waldmann","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.phrs.2016.04.002_bib0160","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2013-03-487850","article-title":"cAMP signaling regulates platelet myosin light chain (MLC) phosphorylation and shape change through targeting the RhoA- Rho kinase-MLC phosphatase signaling pathway","volume":"122","author":"Aburima","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0165","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1021\/bi960128m","article-title":"Inositol 1,4,5-trisphosphate-mediated Ca2+ release from platelet internal membranes is regulated by differential phosphorylation","volume":"35","author":"Quinton","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.phrs.2016.04.002_bib0170","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1073\/pnas.95.4.1613","article-title":"Inhibition of inositol 1,4,5-trisphosphate-induced Ca2+ release by cAMP-dependent protein kinase in a living cell","volume":"95","author":"Tertyshnikova","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.04.002_bib0175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/ATVBAHA.111.241067","article-title":"Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity","volume":"32","author":"Loyau","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0180","doi-asserted-by":"crossref","first-page":"23802","DOI":"10.1016\/S0021-9258(18)54354-4","article-title":"Structure and function studies of the cGMP-stimulated phosphodiesterase","volume":"266","author":"Stroop","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.04.002_bib0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1042\/bj3290505","article-title":"Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation","volume":"329","author":"Turko","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2016.04.002_bib0190","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1073\/pnas.180194597","article-title":"Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs","volume":"97","author":"Yang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.04.002_bib0195","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/ATVBAHA.115.303395","article-title":"Purinergic receptors in thrombosis and inflammation","volume":"35","author":"Hechler","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0200","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1039\/c1mb05145h","article-title":"Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds","volume":"7","author":"Margarucci","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.phrs.2016.04.002_bib0205","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.tips.2013.10.005","article-title":"AKAP signaling complexes: pointing towards the next generation of therapeutic targets?","volume":"34","author":"Esseltine","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2016.04.002_bib0210","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1055\/s-0038-1650707","article-title":"Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes","volume":"76","author":"El-Daher","year":"1996","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2016.04.002_bib0215","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1182\/blood.V95.11.3412","article-title":"Distinct localization and function of (1,4,5)IP(3) receptor subtypes and the (1,3,4,5)IP(4) receptor GAP1(IP4BP) in highly purified human platelet membranes","volume":"95","author":"El-Daher","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/bj3190067","article-title":"Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein CD36","volume":"319","author":"Dorahy","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2016.04.002_bib0225","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0005-2736(03)00022-1","article-title":"Lipid rafts are critical membrane domains in blood platelet activation processes","volume":"1610","author":"Bodin","year":"2003","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.phrs.2016.04.002_bib0230","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1538-7836.2005.01325.x","article-title":"Lipid rafts are required in Galphai signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation","volume":"3","author":"Quinton","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.phrs.2016.04.002_bib0235","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1084\/jem.20020143","article-title":"Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation","volume":"8","author":"Shrimpton","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2016.04.002_bib0240","doi-asserted-by":"crossref","first-page":"18801","DOI":"10.1074\/jbc.M111520200","article-title":"Lipid rafts orchestrate signaling by the platelet receptor glycoprotein VI","volume":"277","author":"Locke","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.04.002_bib0245","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj20020128","article-title":"Differential role of glycolipid-enriched membrane domains in glycoprotein VI- and integrin-mediated phospholipase C\u03b32 regulation in platelets","volume":"364","author":"Wonerow","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.phrs.2016.04.002_bib0250","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1016\/j.febslet.2014.06.057","article-title":"The association of thromboxane A2 receptor with lipid rafts is a determinant for platelet functional responses","volume":"588","author":"Moscard\u00f3","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2016.04.002_bib0255","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/09537104.2014.916792","article-title":"Compartmentalisation of cAMP-dependent signalling in blood platelets: the role of lipid rafts and actin polymerisation","volume":"26","author":"Raslan","year":"2015","journal-title":"Platelets"},{"key":"10.1016\/j.phrs.2016.04.002_bib0260","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fphar.2015.00266","article-title":"The spatiotemporal regulation of cAMP signaling in blood platelets\u2fffold friends and new players","volume":"6","author":"Raslan","year":"2015","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0265","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1182\/blood-2003-12-4330","article-title":"The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage","volume":"104","author":"Jedlitschky","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0270","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2353\/ajpath.2010.090425","article-title":"Role of MRP4 (ABCC4) in platelet adenine nucleotide-storage: evidence from patients with delta-storage pool deficiencies","volume":"176","author":"Jedlitschky","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0275","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2011.03.049","article-title":"Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting","volume":"58","author":"Mattiello","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0280","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1124\/jpet.107.131342","article-title":"ATP-dependent transport of leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4)","volume":"324","author":"Rius","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2016.04.002_bib0285","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2014-08-595942","article-title":"The ABCC4 membrane transporter modulates platelet aggregation","volume":"126","author":"Cheepala","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0290","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1160\/TH12-04-0232","article-title":"Reduction of cAMP and cGMP inhibitory effects in human platelets by MRP4-mediated transport","volume":"108","author":"Borgognone","year":"2012","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.phrs.2016.04.002_bib0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2014.05.001","article-title":"Multidrug resistance protein 4 (MRP4\/ABCC4) regulates thrombus formation in vitro and in vivo","volume":"737","author":"Lien","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0300","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/FPC.0b013e32833997b0","article-title":"Expression of ABC-type transport proteins in human platelets","volume":"20","author":"Niessen","year":"2010","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.phrs.2016.04.002_bib0305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-2275(20)32448-2","article-title":"Characterization of a leukotriene C4 export mechanism in human platelets: possible involvement of multidrug resistance-associated protein 1","volume":"40","author":"Sjolinder","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phrs.2016.04.002_bib0310","doi-asserted-by":"crossref","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","article-title":"MRP4 confers resistance to topotecan and protects the brain from chemotherapy","volume":"24","author":"Leggas","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0315","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood-2015-02-631044","article-title":"Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice","volume":"126","author":"Decouture","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.phrs.2016.04.002_bib0320","doi-asserted-by":"crossref","first-page":"e12034","DOI":"10.14814\/phy2.12034","article-title":"Essential role of vesicular nucleotide transporter in vesicular storage and release of nucleotides in platelets","volume":"2","author":"Hiasa","year":"2014","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.phrs.2016.04.002_bib0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2013.08.005","article-title":"Mechanisms of aspirin resistance","volume":"141","author":"Floyd","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2016.04.002_bib0330","article-title":"High on-aspirin platelet reactivity predicts cardiac death in acute coronary syndrome patients undergoing PCI","volume":"2","author":"Gori","year":"2016","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.phrs.2016.04.002_bib0335","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.108.768283","article-title":"Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk","volume":"118","author":"Eikelboom","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.002_bib0340","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.phrs.2016.04.002_bib0345","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12185-014-1673-0","article-title":"Increased mean platelet volume and immature platelet fraction as potential predictors of thrombotic complications in BCR\/ABL negative myeloproliferative neoplasms","volume":"100","author":"Kissova","year":"2014","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0350","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2004.03.014","article-title":"Rat multidrug resistance protein 4 (MRP4, ABCC4): molecular cloning, organ distribution, postnatal renal expression, and chemical inducibility","volume":"317","author":"Chen","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2016.04.002_bib0355","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/bcp.12432","article-title":"Aspirin influences megakaryocytic gene expression leading to upregulation of multidrug resistance protein-4 in human platelets","volume":"78","author":"Massimi","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.04.002_bib0360","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/607957","article-title":"Multidrug resistance protein-4 influences aspirin toxicity in human cell line","volume":"2015","author":"Massimi","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2016.04.002_bib0365","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vph.2015.06.016","article-title":"Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and multidrug resistance protein 4 expression in human platelets","volume":"76","author":"Temperilli","year":"2015","journal-title":"Vasc. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302638?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816302638?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:26:23Z","timestamp":1655425583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816302638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":73,"alternative-id":["S1043661816302638"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.04.002","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}